Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Humanigen has dosed the first COVID-19 patient in its study for lenzilumab, the company’s GM-CSF monoclonal antibody.
read more
CMC Biologics, Inc., a global leader in process development and contract manufacturing, today announced that it has entered in to a Commercial Supply Agreement with Portola Pharmaceuticals, a biopharmaceutical company for the development of andexanet...
read more
Aptuit has acquired Kuecept Ltd to meet strong customer demand for specialist drug pre-formulation, formulation prototyping and formulation development services.
read more
Thursday, February 23, 2017
Pharmaceutical Product Development has entered into a collaboration with Frenova Renal Research, a drug and medical device contract clinical development services provider dedicated exclusively to renal research.
read more
Tuesday, January 14, 2020
Neurocrine Biosciences and Idorsia announced an amendment to the agreement granting Neurocrine Biosciences an option to license ACT-709478 for a rare pediatric epilepsy.
read more
Silo Pharma, Inc. has entered into an agreement with Frontage Laboratories, a CRO (contract research organization), providing integrated, science-driven, product development services throughout the drug discovery and development process that enable ...
read more
3P Biopharmaceuticals has signed a collaboration agreement with the Dutch biotech company Xenikos that will cover the global manufacturing of Xenikos’ proprietary lead product candidate T-Guard®.
read more
AskBio has acquired Synpromics, a provider of gene control synthetic promoter technology, bioinformatics and intelligent data-driven design that enables more precise cell targeting and gene expression.
read more
Friday, September 06, 2013
Micromeritics Instrument Corporation is proud to announce its national accreditation as a Post-Secondary Avocational/Professional Development Institution by the Accrediting Council for Continuing Education and Training (ACCET), an accrediting agency ...
read more
AI VIVO is seeking pharma and biotech collaboration partners to progress therapeutic candidates that have been identified by the Company as “top-ranked” for COVID-19.
read more
Thursday, November 19, 2020
Adlib announced a rebrand that represents its evolution into an AI-driven, SaaS-based Content Intelligence and Contract Analytics business.
read more
Wednesday, January 27, 2016
Eli Lilly and Company has announced an arrangement to partner with Roche Diagnostics on its ongoing development of a commercially scalable cerebrospinal fluid assay for amyloid-beta 1-42.
read more
Thursday, August 03, 2017
WIRB-Copernicus Group announced that it has acquired Patient Genesis' ConsentNow eConsent technology.
read more
Catalent announced the launch of a next-generation cell line development technology, GPEx® Lightning. Leveraging Catalent’s proven GPEx expression platform in a glutamine synthase (GS) knock-out Chinese hamster ovary (CHO) cell line system, GPEx ...
read more
Pfizer has expanded its research on vaccines to eventually safeguard people from cradle to grave, from shots for pregnant women to protect their babies from the moment of birth to vaccines for senior citizens with waning immune systems
read more